U. Creutzig - Concepedia

Author

U. Creutzig

University Hospital Münster

Also Known As

Creutzig Ursula, Creutzig, U., Creutzig, Ursula, U Creutzig, U. Creutzig, U. Creutzig, Ursula Creutzig

Publications

815

Citations

H-Index

Concepts

All Affiliations

University Hospital Münster Uniwersytecki Szpital Dziecięcy Children's Clinical University Hospital Temple Street Children's University Hospital

About

U. Creutzig is an author at University Hospital Münster specializing in medicine, hematology, and pediatrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	403
2	Health Sciences	1	1	13
3	Immunology	1	1	13
4	Pediatric Surgery	1	1	228
5	Pharmacology	1	1	13

U. Creutzig

Publications

608

Citations

H-Index

Page 1

	Year	Citations
Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials U. Creutzig, M Zimmermann, J. Ritter, Leukemia NeonatologyPediatric EpidemiologyPediatric HematologyClinical TrialsPediatrics	2005	228
Improved Treatment Results in Childhood Acute Myelogenous Leukemia: An Update of the German Cooperative Study AML-BFM-78 J. Ritter, U. Creutzig, Hansjörg Riehm, Hämatologie und Bluttransfusion Hematological MalignancyOncologyPediatric HematologyMixed-phenotype Acute LeukemiaHematology	1985	162
Immunophenotype of Down Syndrome Acute Myeloid Leukemia and Transient Myeloproliferative Disease Differs Significantly from Other Diseases with Morphologically Identical or Similar Blasts Claudia Langebrake, U. Creutzig, Dirk Reinhardt Klinische Pädiatrie	2005	93
In vitro chemosensitivity assessed with the MTT assay in childhood acute non-lymphoblastic leukemia. E. Klumper, Rob Pieters, Gertjan J.L. Kaspers, PubMed	1995	55
Primary myelosarcomas are associated with a high rate of relapse: report on 34 children from the acute myeloid leukaemia–Berlin–Frankfurt–Münster studies Dirk Reinhardt, Arnulf Pekrun, M. Lakomek, British Journal of Haematology	2000	28
Treatment results of three consecutive German childhood AML trials: BFM-78, -83, and -87. AML-BFM-Group. J. Ritter, U. Creutzig, G. Schellong PubMed	1992	19
Potentiation of <i>in vitro</i> ara‐C cytotoxicity by ribonucleotide reductase inhibitors, cyclin‐dependent kinase modulators and the DNA repair inhibitor aphidicolin in paediatric acute myeloid leukaemia Isabelle Hubeek, Godefridus J. Peters, A. J. F. Broekhuizen, British Journal of Haematology ImmunologyPharmacotherapyMyeloid NeoplasiaHematological MalignancyDrug Resistance	2005	13
Cytogenetic Findings in Acute Leukemias of Infants1 Jochen Harbott, J. Ritterbach, U. Creutzig, Beiträge zur Onkologie/Contributions to oncology	1990	10

Page 1